AbbVie Inc. (ABBV) Stock Overview
Explore AbbVie Inc.’s financial performance, market position, analyst ratings, and future outlook.
AbbVie Inc. (ABBV)
Key Financials
Key Financials
Market Cap
465.1B
P/E Ratio
74.30
EPS (TTM)
$10.19
ROE
-1.36%
ABBV Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of AbbVie Inc. (NYSE: ABBV) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, AbbVie Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ABBV on the NYSE shows an RSI of 54.51, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $241.53 for the NYSE listing.
Key metrics behind AbbVie Inc.'s NYSE-traded stock include a P/E ratio of 74.30 and a market capitalization of 465.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ABBV on the NYSE.